Prescription Amphetamines and Semen Testing: Why Lower Total Motile Count Did Not Mean Lower Sperm Concentration

Written by

in

A semen result can change because the sample contains less fluid, because it contains fewer sperm per milliliter, or because a smaller proportion of sperm move. These are different observations. A historical study of prescription stimulants illustrates why a report about total motile sperm count should not automatically become a claim that amphetamines damaged sperm production.

What population and exposure did the study examine?

Pham and colleagues retrospectively examined 8,861 adult men undergoing fertility-related semen testing in one academic healthcare system between March 2002 and October 2020. Of these, 106 had an active outpatient stimulant prescription within 90 days before testing; 8,755 had no documented exposure. The study excluded several diagnoses and medications that could complicate reproductive interpretation.

The exposed category combined methylphenidate with amphetamines and related derivatives. Ninety-two exposed men had amphetamine prescriptions, 18 had methylphenidate prescriptions, and four had both categories. This was not a study confined to methamphetamine, illicit stimulant use, or one verified dose and route.

Which semen outcomes differed?

After adjustment for age and any non-stimulant medication use, stimulant exposure was associated with lower semen volume: a regression coefficient of −0.35 mL, standard error 0.16, p = 0.035. The adjusted coefficient for total motile sperm count was −18.00 million per ejaculate, standard error 8.44, p = 0.033. Concentration, motility and morphology did not show significant associations.

Total motile count also requires attention to the analysis: the unadjusted comparison was not statistically significant. Median values were 71.60 versus 72.49 million per ejaculate, p = 0.19. Those estimates came from 92 exposed and 8,201 unexposed men with available data, rather than every member of the overall cohort.

How can volume matter without a concentration difference?

Total motile sperm count combines sample volume, sperm concentration and the motile fraction. Lower volume can therefore accompany a lower total number of moving sperm even when concentration per milliliter is similar. Reporting only the total count conceals that distinction.

The significant adjusted result and the non-significant unadjusted result answer different statistical questions. Neither should be omitted to make the study appear uniformly positive or uniformly negative. Adjustment can account for measured differences between groups; it cannot turn a retrospective comparison into random assignment.

Does this establish infertility caused by amphetamine?

No. The investigators could not confirm medication adherence or accurately determine exposure duration. A prescription window is an administrative exposure definition, not proof of continuous ingestion. The control group could also contain undocumented stimulant exposure. Treating all other medications as one yes-or-no covariate leaves substantial room for differences that were not fully characterized.

The outcome was laboratory semen parameters in a selected care population. A coefficient for a group comparison is not an individual prediction of conception or a diagnosis of infertility. Nor can this pooled exposure analysis establish the effect of a particular amphetamine formulation, dose, route or pattern of use.

What should an evidence-based interpretation preserve?

Preserve the specimen, endpoint and exposure definition together: semen measurements, a prescription-based stimulant category, and associations within fertility-related care. Keep the null findings beside the volume and adjusted total-count results. This historical evidence supports a carefully framed research question; it does not supply a medication-stopping schedule, a methamphetamine-specific causal conclusion or a contemporary treatment recommendation.

Source

Pham MN and colleagues. The adverse association between stimulant use for attention deficit hyperactivity disorder (ADHD) and semen parameters. Andrologia. 2022;54(2):e14315. Published online November 23, 2021. DOI: 10.1111/and.14315. Full text; verified bibliographic record.